Obesity trials in Austria
10 of 16 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
- Where
- Braunau Am Inn, Graz, Klagenfurt Am Woerthersee, Linz, Salzburg, St. Poelten, Vienna
- Age
- 18 years and over
- People
- 2,787 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-516654-22-00 - Phase 3Taking peopleMirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Where
- Graz, Innsbruck, Vienna
- Age
- 18 years to 70 years
- People
- 350 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00 - Phase 3Taking peopleMirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Where
- Graz, Innsbruck, Vienna
- Age
- 18 years to 70 years
- People
- 290 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00 - Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Braunau am Inn, Graz, Klagenfurt, Linz, Salzburg, Sankt Pölten, Vienna
- Age
- 18 years to 99 years
- People
- 5,056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459 - Phase 3Taking peopleA Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Where
- Innsbruck, Salzburg
- Age
- 8 years to 18 years
- People
- 460 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07253285 · EU 2023-509176-42-00 - Phase 3Taking peopleA Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Where
- Graz, Mattersburg, St. Stefan ob Stainz, Vienna, Wien
- Age
- 18 years and over
- People
- 2,500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00 - Phase 1Not yet taking people in AustriaA Research Study Looking Into How a High Dose of s.c. Semaglutide Works With Emptying of the Stomach in People With Excess Body Weight
- Where
- Graz
- Age
- 18 years to 64 years
- People
- 60
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07845578 · EU 2026-526083-20-00 - No phaseTaking peopleEffects of Akkermansia Muciniphila and Berberine Supplementation on Insulin Sensitivity in Night-shift Workers
- Where
- Graz
- Age
- 21 years and over
- People
- 200
- Run by
- FH Joanneum Gesellschaft mbH
See details and how to joinNCT07440147 - No phaseTaking peopleESAN II - Energy Sensing in Depression
- Where
- Graz
- Age
- 18 years to 40 years
- People
- 120
- Run by
- Medical University of Graz
See details and how to joinNCT05432362 - Phase 4Taking peopleEffects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and Hypogonadism
- Where
- Vienna
- Age
- 18 years to 75 years
- People
- 32
- Run by
- Alexandra Kautzky-Willer
See details and how to joinNCT03851627 · EU 2023-509819-87-00